This article is from the archives of the UB Reporter.
Archives

Henderson to receive award

Published: February 16, 2006

By LOIS BAKER
Contributing Editor

Donald Henderson, professor in the Department of Communicative Disorders and Sciences, College of Arts and Sciences, will receive the 2006 Outstanding Hearing Conservation Award from the National Hearing Conservation Association on Saturday at the association's annual conference in Tampa.

A leading scientist at UB's Center for Hearing and Deafness, Henderson has been at the forefront of international research to determine the biological mechanisms through which toxins and noise exposure kill hair cells, the organs in the inner ear responsible for transmitting sound to the brain's hearing center.

This work has led to two patents for new drugs to prevent or reverse the loss.

Henderson's research group was the first to show that noise exposure increases the level of oxygen free radicals in the cochlea, which destroy hair cells. The research has shown further that this destruction can be slowed or prevented through two approaches: by conditioning the hair cells to withstand noise, and by using antioxidants to protect the hair cells from free radicals.

In conjunction with other colleagues at the center, Henderson has shown that a protein kinase inhibitor developed by David Hangauer, UB associate professor of chemistry, to treat cancer has significant promise to prevent noise-induced hearing loss by blocking hair cell death.

Another drug Henderson was instrumental in developing has proven effective in lessening hearing loss due to exposure to deafening battle noise in tests conducted by the U.S. military.

Henderson, along with Richard Salvi, professor of communicative disorders and sciences and director of the Center for Hearing and Deafness, was instrumental in arranging an international symposium held last October that focused on major developments in research, treatment and prevention of acquired hearing loss and tinnitus.

He was honored by UB in 2004 and 2005 for his work in drug development for hearing loss.